Vaccination & COVID 19

Biography

Julia Schaletzky is the Executive Director of the Center for Emerging and Neglected Diseases at UC Berkeley. Trained as a biochemist at Bayreuth University, LMU Munich and Harvard University/HHMI, she holds a PhD in cell biology. Dr. Schaletzky joined a biotechnology company, Cytokinetics, and focused on discovering and developing novel, first-in-class medicines against heart failure and neurodegenerative disorders such as ALS, which are currently in Phase III clinical trials. She also founded the UCB Drug Discovery Center, which opened just in time to make an impact in the Covid-19 pandemic. Julia is passionate about treating neglected and emerging diseases, establishing effective collaboration between academia and industry and about translating basic science into new companies and ultimately cures.